Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1373574 | Bioorganic & Medicinal Chemistry Letters | 2007 | 6 Pages |
Abstract
A new series of 1-(1,3-benzodioxol-5-ylmethyl)-3-[4-(1H-Imidazol-1-yl)phenoxy]-piperidine analogs were designed and identified as potent and selective inhibitors of NO formation based both on the crystal structure of a murine iNOS Δ114 monomer domain/ inhibitor complex and inhibition of the NO formation in human A172 cell assays. Compound 12S showed high potency and high iNOS selectivity versus nNOS and eNOS.
Graphical abstractA new series of 1-(1,3-benzodioxol-5-ylmethyl)-3-[4-(1H-Imidazol-1-yl)phenoxy]- piperidine analogs were discovered as potent and selective inhibitors of NO formation. Compound 12S showed high potency and high iNOS selectivity versus nNOS and eNOS.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Robert G. Wei, Marc Adler, David Davey, Elena Ho, Raju Mohan, Mark Polokoff, Jih-Lie Tseng, Marc Whitlow, Wei Xu, Shendong Yuan, Gary Phillips,